Mem Inst Oswaldo Cruz, Rio de Janeiro, FAST TRACK
Low risk of serological cross-reactivity between dengue and COVID-19
1Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy
2Infectious and Tropical Diseases Unit, Careggi University Hospital, Florence, Italy
3Microbiology and Virology Unit, Careggi University Hospital, Florence, Italy
In the near future, the overlap of COVID-19 and dengue epidemics is a concrete threat in tropical regions. Co-epidemics of COVID-19 and dengue could be an overwhelming challenge for health systems in low- and middle-income countries. In this work, we investigated potential serological cross-reactions between COVID-19 and dengue patients. Further data on accuracy of COVID-19 diagnostic test are urgently warranted.